6533b826fe1ef96bd1284f26

RESEARCH PRODUCT

Retraction notice to “Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine” [J Psychiat Res 44 (2010) 754–759]

Peter SchneiderAndreas HertelGeorg NikischGeorg WiedemannHeike WeisserAleksander A. MathéMichael ReinertBernhard KießlingPierre BaumannFrank RoeschJan KehrMarkus Piel

subject

DrugNoticemedia_common.quotation_subjectPharmacologyFirst episode schizophreniaPsychiatry and Mental healthCerebrospinal fluidMonoamine neurotransmitterAnesthesiaDopamine receptor D2medicineQuetiapineIn patientPsychologyBiological Psychiatrymedicine.drugmedia_commonhttps://doi.org/10.1016/j.jpsychires.2012.05.012